Search

Joost Oppenheim Phones & Addresses

  • 5809 Nicholson Ln, Rockville, MD 20852 (301) 881-1188
  • 5809 Nicholson Ln APT 809, Rockville, MD 20852 (301) 881-1188
  • North Bethesda, MD
  • Washington, DC
  • 7601 Winterberry Ct, Bethesda, MD 20817 (301) 320-3217
  • 5809 Nicholson Ln APT 809, Rockville, MD 20852 (301) 320-3217

Work

Company: NATIONAL CANCER INSTITUTE Address: 1050 Boyles St Suite 2189A, Frederick, MD 21702 Phones: (301) 846-1551 (301) 846-7042

Education

School / High School: Columbia University / College of Physicians And Surgeons 1960

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Allergy & Immunology, 1977

Specialities

Allergy & Immunology

Professional Records

Medicine Doctors

Joost Oppenheim Photo 1

Dr. Joost J Oppenheim, Frederick MD - MD (Doctor of Medicine)

View page
Specialties:
Allergy & Immunology
Address:
NATIONAL CANCER INSTITUTE
1050 Boyles St Suite 2189A, Frederick, MD 21702
(301) 846-1551 (Phone), (301) 846-7042 (Fax)
Certifications:
Allergy & Immunology, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1960
Medical School
King Co Hosp
Graduated: 1960
Medical School
University Of Washington Medical Center
Graduated: 1960
Medical School
U Birmingham
Graduated: 1960

Resumes

Resumes

Joost Oppenheim Photo 2

Lab Chief

View page
Location:
Washington, DC
Industry:
Government Relations
Work:
NCI
Lab Chief
Joost Oppenheim Photo 3

Joost Oppenheim

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Joost Oppenheim
Molecular Immunoregulation Laboratory
National Institutes of Health
Administration of Public Health Programs
9000 Rckvlle Pike Bldg 31, Bethesda, MD 20892
Joost Oppenheim
Chief Of The Laboratory Of Molecular Immunoregulation
National Institutes of Health
Administration of Public Health Programs
9000 Rockville Pike, Bethesda, MD 20892
Joost Oppenheim
Editor
International Soceity for Pharmacoepidemiology
Civic & Social Association
5272 Riv Rd, Bethesda, MD 20816
(301) 634-7949
Joost Oppenheim
Editor
The Society for Leukocyte Biology Inc
Noncommercial Research Organization/Scientific Society · Scientific Society
9650 Rockville Pike, Bethesda, MD 20814
(301) 634-7810
Joost Oppenheim
Molecular Immunoregulation Laboratory
National Institutes of Health
Administration of Public Health Programs
9000 Rckvlle Pike Bldg 31, Bethesda, MD 20892
Joost Oppenheim
Chief Of The Laboratory Of Molecular Immunoregulation
National Institutes of Health
Administration of Public Health Programs
9000 Rockville Pike, Bethesda, MD 20892

Publications

Isbn (Books And Publications)

Immunophysiology: The Role of Cells And Cytokines in Immunity And Inflammation

View page
Author

Joost J. Oppenheim

ISBN #

0195050975

Clinical Applications of Cytokines: Role in Pathogenesis, Diagnosis, and Therapy

View page
Author

Joost J. Oppenheim

ISBN #

0195071298

Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense

View page
Author

Joost J. Oppenheim

ISBN #

0122526708

Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense

View page
Author

Joost J. Oppenheim

ISBN #

0122526732

Interleukins, Lymphokines and Cytokines

View page
Author

Joost J. Oppenheim

ISBN #

0125275404

Mitogens in Immunobiology

View page
Author

Joost J. Oppenheim

ISBN #

0125275501

Cellular Functions in Immunity and Inflammation

View page
Author

Joost J. Oppenheim

ISBN #

0444005544

Monokines and Other Non Lymphocytic Cytokines: Proceedings

View page
Author

Joost J. Oppenheim

ISBN #

0471620408

Us Patents

Nucleic Acids Encoding A Novel Neutrophil Chemotactic Factor

View page
US Patent:
6376659, Apr 23, 2002
Filed:
Mar 14, 1997
Appl. No.:
08/818631
Inventors:
Kouji Matsushima - Frederick MD
Teizo Yoshimura - Frederick MD
Edward J. Leonard - Chevy Chase MD
Joost Oppenheim - Bethesda MD
Ettore Appella - Chevy Chase MD
Stephen D. Showalter - Frederick MD
Assignee:
The United States of America, as represented by the Department of Health and Human Services - Washington DC
International Classification:
C12N 1519
US Classification:
536 235, 435 695, 4353201
Abstract:
An isolated, synthetic preparation of a novel neutrophil-specific chemotactic factor (NCF), monoclonal antibodies having specific binding affinity of NCF and a clone containing the complete cDNA coding sequence for NCF are disclosed.

Neutrophil Chemotactic Factor Cloned Cdna And Monoclonal Antibodies Thereto

View page
US Patent:
6475741, Nov 5, 2002
Filed:
Nov 9, 2001
Appl. No.:
10/037218
Inventors:
Kouji Matsushima - Frederick MD
Teizo Yoshimura - Frederick MD
Edward J. Leonard - Chevy Chase MD
Joost Oppenheim - Bethesda MD
Ettore Appella - Chevy Chase MD
Stephen D. Showalter - Frederick MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C12Q 168
US Classification:
435 6, 424 851, 530351, 435 695, 435 6952
Abstract:
An isolated, synthetic preparation of a novel neutrophil-specific chemotactic factor (NCF), monoclonal antibodies having specific binding affinity for NCF and a clone containing the complete cDNA coding sequence for NCF are disclosed.

Ureido Derivatives Of Poly-4-Amino-2-Carboxy-1-Methyl Pyrrole Compounds For Inhibition Of Inflammation

View page
US Patent:
6562859, May 13, 2003
Filed:
Aug 4, 2000
Appl. No.:
09/555733
Inventors:
O. M. Zack Howard - Frederick MD
Joost J. Oppenheim - Bethesda MD
William J. Murphy - Frederick MD
Edward A. Sausville - Silver Spring MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 3140
US Classification:
514422, 514518
Abstract:
A method of using a ureido derivative of a poly-4-amino-2-carboxy-1-methyl pyrrole or a pharmaceutically acceptable salt thereof to inhibit inflammation, particularly non-TNF- dependent inflammation, in a mammal.

Ligands For Fpr Class Receptors That Induce A Host Immune Response To A Pathogen Or Inhibit Hiv Infection

View page
US Patent:
6808877, Oct 26, 2004
Filed:
Jul 17, 2002
Appl. No.:
10/199228
Inventors:
Ji-Ming Wang - Frederick MD
Yingying Le - Frederick MD
WangHua Gong - Frederick MD
Bao Qun Li - Frederick MD
Thomas Rogers - North Wales PA
Philip Murphy - Rockville MD
Joost J. Oppenheim - Bethesda MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C12Q 170
US Classification:
435 5, 435 724, 435329, 4241841, 4242041, 4242081
Abstract:
The present invention relates to the discovery of molecules that inhibit viral infection and promote a host immune response to a pathogen. More specifically, the invention disclosed herein concerns molecules that interact with a FPR class receptor, inhibit HIV infection, and stimulate an inflammatory response in a subject. Embodiments of the invention include biotechnological tools, prophylactics, therapeutics, and methods of use of the foregoing, for the study, treatment, and prevention of HIV infection and the induction of an inflammatory response in a subject.

T20/Dp178 Is An Activator Of Human Phagocyte Formyl Peptide Receptors

View page
US Patent:
6830893, Dec 14, 2004
Filed:
Nov 2, 2001
Appl. No.:
10/005305
Inventors:
Ji Ming Wang - Frederick MD
Joost J. Oppenheim - Bethesda MD
Wang Hua Gong - Frederick MD
Ji-Liang Gao - Frederick MD
Philip M. Murphy - Rockville MD
Assignee:
The United States of America as represented by the Department of Health Human Services - Washington DC
International Classification:
G01N 3350
US Classification:
435 71, 436501
Abstract:
The present invention relates to the discovery that T20/DP178, T21/DP107, and fragments thereof interact with members of the formyl peptide receptor family and thereby modulate cell migration and activation. Novel biological tools, prophylactics, therapeutics and methods of use of the foregoing for modulating an inflammatory response are disclosed.

Hmgn Polypeptides As Immune Enhancers And Hmgn Antagonists As Immune Suppressants

View page
US Patent:
8227417, Jul 24, 2012
Filed:
Jul 24, 2009
Appl. No.:
12/509088
Inventors:
De Yang - Frederick MD, US
Joost J. Oppenheim - Bethesda MD, US
Michael Bustin - Rockville MD, US
Assignee:
The United States of America as represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
A61K 38/19
US Classification:
514 193, 514 24
Abstract:
A method of enhancing an antigen-specific immune response in a host comprising administering to the host an HMGN polypeptide comprising at least one of HMGN1, HMGN3a, HMGN3b, HMGN4, Nsbp1, or a functional fragment thereof, in an amount effective to enhance an antigen-specific immune response; as well as a pharmaceutical composition comprising an HMGN polypeptide comprising at least one of HMGN1, HMGN3a, HMGN3b, HMGN4, Nsbp1, or a functional fragment thereof, and an antigen, or nucleic acids encoding such molecules; and related methods and compositions.

Ll-37 Is An Immunostimulant

View page
US Patent:
20020072495, Jun 13, 2002
Filed:
Sep 21, 2001
Appl. No.:
09/960876
Inventors:
Oleg Chertov - Frederick MD, US
Joost Oppenheim - Bethesda MD, US
De Yang - Frederick MD, US
Glenn Anderson - Norristown PA, US
Joseph Wooters - Brighton MD, US
International Classification:
A61K038/17
US Classification:
514/012000
Abstract:
The present invention provides a method of enhancing an immune response in a subject, comprising administering an effective amount of LL-37. Moreover, the present invention provides a method of enhancing in a subject an immune response to a vaccine, comprising administering to the subject an effective amount of LL-37 with a vaccine. Further provided is a method of detecting a compound that decreases an immune response in a subject. A method of treating an autoimmune disease in a subject is thus provided. Also provided is a vaccine comprising an immunogen and LL-37.

Utilization Of Fprl1 As A Functional Receptor By Serum Amyloid A (Saa)

View page
US Patent:
20030120037, Jun 26, 2003
Filed:
Mar 14, 2002
Appl. No.:
10/099782
Inventors:
Ji Ming Wang - Frederick MD, US
Joost Oppenheim - Bethesda MD, US
Wang Hua Gong - Frederick MD, US
Ji-Liang Gao - Frederick MD, US
Philip Murphy - Rockville MD, US
International Classification:
A61K038/17
C07K014/705
C12P021/02
C12N005/06
G01N033/53
G01N033/567
C07H021/04
US Classification:
530/350000, 435/007200, 435/069100, 435/320100, 435/325000, 514/012000, 536/023500
Abstract:
The present invention relates to the discovery that serum amyloid A (SAA) is a ligand for the FPRL1 receptor. Disclosed herein, are novel biological tools for the study of SAA/FPRL1 complex assembly and prophylactics, therapeutics, and methods of use of the foregoing, which modulate the association of SAA with FPRL1 and thereby effect responses including, but not limited to, signal transduction, chemotaxis, leukocyte migration, immune system response, amyloidosis, inflammatory response, infection, organ rejection, arthritis, atherosclerosis, and neoplasia.
Joost J Oppenheim from Rockville, MD, age ~90 Get Report